CDSCO extends consent to import drugs with less than 60 per cent residual shelf life by three months Read more
CSIR seeks regulatory nod for clinical trials using combination of antivirals and HDTs against COVID-19 Read more
Industry recommends changes in draft guidelines for discontinuation of scheduled formulations Read more